AI
It has also received Australia's regulatory approval for its AI solution.
Also, New Zealand's The Doctors has cautioned the public about a mobile app posing as its official app.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Cloudphysician targets to enter the United States, the Middle East, and Southeast Asia with its smart ICU and emergency department solutions.
Interestingly, young physicians see more risk to it than their senior counterparts.
It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.
The research agreement aims to allow paralyzed patients to communicate and use mobile devices.
The company plans to use the funds to further its AI development and create new hybrid solutions.
The companies plan to reduce burnout and support diagnosis efficiency through new AI-powered applications.